Evidence map›Paper›PMID 39052720›Full record

ArticleThe Journal of infectious diseases2024

Effectiveness of Influenza Vaccination During Pregnancy Against Laboratory-Confirmed Seasonal Influenza Among Infants Under 6 Months of Age in Ontario, Canada.

Deshayne B Fell, Margaret Russell, Stephen G Fung, Sarah Swayze, Hannah Chung, Sarah A Buchan, Weston Roda, Christa Smolarchuk, Kumanan Wilson, Natasha S Crowcroft and 14 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Global vaccine development.Nature medicine · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Deshayne B FellSchool of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.ORCID 0000-0002-5548-3228
Margaret RussellCumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Stephen G FungResearch Institute, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Sarah SwayzePopulations and Public Health, ICES, Toronto and Ottawa, Ontario, Canada.
Hannah ChungPopulations and Public Health, ICES, Toronto and Ottawa, Ontario, Canada.ORCID 0000-0002-9463-3591
Sarah A BuchanPopulations and Public Health, ICES, Toronto and Ottawa, Ontario, Canada.
Weston RodaMathematical and Statistical Sciences, University of Alberta, Edmonton, Alberta, Canada.
Christa SmolarchukAnalytics and Performance Reporting Branch, Health Standards, Quality and Performance Division, Alberta Health, Edmonton, Alberta, Canada.
Kumanan WilsonDepartment of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Natasha S CrowcroftDepartment of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland.ORCID 0000-0002-6761-8783
Kevin L SchwartzPopulations and Public Health, ICES, Toronto and Ottawa, Ontario, Canada.
Jonathan B GubbayHealth Protection, Public Health Ontario, Toronto, Ontario, Canada.
Allison J McGeerDalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Marek SmiejaDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0003-1655-3761
David C RichardsonDepartment of Pathology and Laboratory Medicine, William Osler Health System, Brampton, Ontario, Canada.
Kevin KatzDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
George ZahariadisNewfoundland and Labrador Public Health Laboratory, St John's, Newfoundland and Labrador, Canada.
Aaron CampigottoDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Samira MubarekaDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
J Dayre McNallyChildren's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Timothy KarnauchowChildren's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Nathan ZelyasAlberta Public Health Laboratory, Alberta Precision Laboratories, Edmonton, Alberta, Canada.
Lawrence W SvensonAnalytics and Performance Reporting Branch, Health Standards, Quality and Performance Division, Alberta Health, Edmonton, Alberta, Canada.
Jeffrey C KwongPopulations and Public Health, ICES, Toronto and Ottawa, Ontario, Canada.ORCID 0000-0002-7820-2046

Funding

Canadian Immunization Research Network through a grant from the Public Health Agency of Canada and the Canadian Institutes of Health Research CNF 151944CareICESMinistry of Long-TermOntario Ministry of Health and the Ministry of Long-Term CareUniversity of TorontoWorld Health Organization 001
6 · The paper itself

Abstract

backgroundRandomized trials conducted in low- and middle-income settings demonstrated efficacy of influenza vaccination during pregnancy against influenza infection among infants <6 months of age. However, vaccine effectiveness (VE) estimates from settings with different population characteristics and influenza seasonality remain limited.

methodsWe conducted a test-negative study in Ontario, Canada. All influenza virus tests among infants <6 months from 2010 to 2019 were identified and linked with health databases to ascertain information on maternal-infant dyads. VE was estimated from the odds ratio for influenza vaccination during pregnancy among cases versus controls, computed using logistic regression with adjustment for potential confounders.

resultsAmong 23 806 infants tested for influenza, 1783 (7.5%) were positive and 1708 (7.2%) were born to mothers vaccinated against influenza during pregnancy. VE against laboratory-confirmed infant influenza infection was 64% (95% confidence interval [CI], 50%-74%). VE was similar by trimester of vaccination (first/second, 66% [95% CI, 40%-80%]; third, 63% [95% CI, 46%-74%]), infant age at testing (0 to <2 months, 63% [95% CI, 46%-75%]; 2 to <6 months, 64% [95% CI, 36%-79%]), and gestational age at birth (≥37 weeks, 64% [95% CI, 50%-75%]; < 37 weeks, 61% [95% CI, 4%-86%]). VE against influenza hospitalization was 67% (95% CI, 50%-78%).

conclusionsInfluenza vaccination during pregnancy offers effective protection to infants <6 months, for whom vaccines are not currently available.

Indexed as

Influenza, HumanInfluenza VaccinesVaccinationVaccine EfficacyAdultFemaleHumansInfantInfant, NewbornMaleOntarioPregnancyPregnancy Complications, InfectiousSeasonsYoung AdultInfluenza Vaccineseffectivenessinfluenzapregnancyvaccination

Identifiers

PMID39052720
PMCPMC11272077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.